10,000 cancer patients to help unlock power of personalized medicine

NCT ID NCT02478931

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting information from up to 10,000 cancer patients to see if choosing treatments based on the genetic makeup of their tumors leads to better outcomes. Researchers will look at medical records and may test leftover tissue or blood samples to create a genetic profile of each person's cancer. The goal is to learn whether personalized treatment improves response and reduces side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that tailoring cancer treatment based on a tumor's genetic profile leads to better response and fewer side effects.
What could go wrong
This is an observational study, not a controlled trial. Results may show associations but not prove cause and effect. It may not lead to immediate changes in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eisenhower Medical Center, Lucy Curci Cancer Center

    RECRUITING

    Rancho Mirage, California, 92270, United States

    Contact Email: •••••@•••••

  • Rady Children's Hospital, San Diego

    RECRUITING

    San Diego, California, 92123, United States

  • UCSD Moores Cancer Center

    RECRUITING

    La Jolla, California, 92093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.